PMID: 20577124
Question: Is leptin involved in phagocytic NADPH oxidase overactivity in obesity?
Correct Answer: yes

======================= Launch the MCC process =======================
PMID: 20577124
Question: Is leptin involved in phagocytic NADPH oxidase overactivity in obesity?

----- GPT's initial response -----
GPT is reasoning the answer...


**1. Question Analysis**
- **Core Content:** The question seeks to determine whether leptin plays a role in the overactivity of phagocytic NADPH oxidase in the context of obesity.
- **Key Information to Identify:** 
  - Relationship between leptin levels and NADPH oxidase activity in obese individuals.
  - Experimental evidence showing leptin’s effect on NADPH oxidase.
  - Mechanistic insights into how leptin may influence NADPH oxidase activity.

**2. Evidence Evaluation**
- **Research Results and Data:** 
  - The study found that both leptin levels and NADPH oxidase activity were significantly higher in obese patients compared to controls.
  - There was a positive correlation between leptin levels and NADPH oxidase activity in obese individuals, which remained significant in multivariate analysis.
  - In-vitro experiments demonstrated that leptin induces NADPH oxidase activation.
  - Inhibition studies indicated that leptin’s effect on NADPH oxidase involves specific signaling pathways (phosphatidylinositol 3-kinase and protein kinase C).
- **Strength and Reliability:** 
  - The study included a substantial sample size (164 obese and 94 control individuals).
  - Multiple methods were used to assess the relationship, including in-vivo correlations and in-vitro mechanistic studies, enhancing the reliability of the findings.
- **Relevance to the Question:** 
  - Directly addresses the involvement of leptin in NADPH oxidase activity within the context of obesity.
  - Provides both correlative and mechanistic evidence supporting the role of leptin.

**3. Conclusion**
Based on the provided abstract, there is strong evidence suggesting that leptin is involved in the overactivity of phagocytic NADPH oxidase in obesity. The study demonstrates a positive correlation between leptin levels and NADPH oxidase activity in obese individuals and provides mechanistic insights through in-vitro experiments.

**4. Final Answer**
**My final choice is: "yes"**
GPT selected: yes

----- Qwen's initial response -----
Qwen is reasoning the answer...


**1. Question Analysis**  
The question asks whether leptin contributes to increased phagocytic NADPH oxidase activity in obesity. Key points to assess are:  
- Whether the study links leptin levels to NADPH oxidase activity in obesity.  
- Evidence of a causal or correlative relationship between leptin and NADPH oxidase overactivity.  
- Whether in vitro or clinical data support this relationship.  

**2. Evidence Evaluation**  
- **Human Data**: The study shows that both plasma leptin and NADPH oxidase activity are elevated in obese patients compared to controls (P<0.05). A significant positive correlation between leptin and NADPH oxidase activity persists in multivariate analysis, indicating an independent association.  
- **In Vitro Data**: Leptin directly induced NADPH oxidase activation in human peripheral blood mononuclear cells and murine macrophages. The involvement of specific pathways (PI3K/PKC) was confirmed by inhibitors (wortmannin and bisindolyl maleimide), strengthening the causal link.  
- **Clinical Relevance**: The study also links leptin and NADPH oxidase activity to carotid intima-media thickness (cIMT), a marker of vascular remodeling/atherosclerosis, further supporting a pathophysiological role.  

The evidence is robust, combining human observational data with mechanistic in vitro experiments, and the conclusion explicitly states that hyperleptinemia "may contribute" to NADPH oxidase overactivity.  

**3. Conclusion**  
The study provides strong correlative and causal evidence (in vitro) that leptin directly enhances NADPH oxidase activity in obesity. The abstract’s conclusion aligns with the findings, leaving little ambiguity. Thus, the answer should be "yes."  

**4. Final Answer:**  
**My final choice is: "yes"**
Qwen selected: yes

----- Deepseek's initial response -----
DeepSeek is reasoning the answer...

**1. Question Analysis**  
The question asks whether leptin contributes to phagocytic NADPH oxidase overactivity in obesity. Key elements to identify in the abstract include: (1) associations between leptin levels and NADPH oxidase activity in obese patients, (2) experimental evidence of leptin directly activating NADPH oxidase, and (3) mechanistic insights linking leptin to NADPH oxidase pathways.

**2. Evidence Evaluation**  
- **Observational Data**: Obese patients exhibited elevated leptin levels and NADPH oxidase activity, with a significant positive correlation between the two. This association persisted in multivariate analysis, suggesting leptin’s independent role.  
- **In-Vitro Experiments**: Leptin directly induced NADPH oxidase activation in human and murine cells. Pharmacological inhibition (wortmannin, bisindolyl maleimide) implicated PI3-kinase and PKC pathways in this process.  
- **Clinical Relevance**: Leptin-driven NADPH oxidase activation correlated with increased carotid intima-media thickness (cIMT), a marker of preclinical atherosclerosis.  
- **Strength**: The study combines human observational data with mechanistic in vitro experiments, strengthening causality. The sample size (164 obese vs. 94 controls) adds reliability.  

**3. Conclusion**  
The evidence strongly supports leptin’s role in promoting phagocytic NADPH oxidase overactivity in obesity. Both correlative human data and direct experimental evidence confirm leptin’s involvement via specific signaling pathways. The authors explicitly state that hyperleptinemia "may contribute" to this overactivity, aligning with the findings.  

**4. Final Answer**  
**My final choice is: yes**
DeepSeek selected: yes

Initial consensus: All models selected yes